Policymakers face a daunting task in closing the yawning gap between revenues and expenditures in the coming years, but targeting medical innovation is a particularly counterproductive approach.

FORBES: Beyond The Fiscal Cliff, Pharmaceutical Innovation Is The Key To Long-Term Fiscal Health